TechCrunchSynbioBeta Launches Venture Fund for Synthetic Biology StartupsLabiotech.eu (blog)US-based venture capital fund Data Collective has announced that it is partnering with SynBioBeta to launch a new synthetic biology venture fund.Data Collective… Continue reading
|
CBMG completes Wuxi stem cell plant expansion
BioPharma-Reporter.com The firm said: “By the end of 2017, the Company anticipates that the combination of this Wuxi site, the new Zhangjiang Shanghai and the Beijing GMP facilities will be capable of supporting simultaneous clinical trials for five different CAR-T and stem … |
|
RepliCel Life Sciences, a Stem Cell Franchise Meeting Truly Unmet Needs in Medicine
Yahoo Finance V) gave patients and investors the verdict on the company’s first-in-human phase 1/2 study of its stem cell candidate RCT-01 (type 1 collagen-expressing, hair follicle-derived autologous fibroblasts suspended in cryomedium). RCT-01 cleared its initial … |
|
US Stem Cell Inc (OTCMKTS:USRM) Stock Has a Powerful New Weapon
The Oracle Dispatch US Stem Cell Inc (OTCMKTS:USRM) is a stock we pointed to back in early March as a potential runner. We’ve seen about 230% on the upside since that time, and the company continues to frame its narrative with new catalysts. According to the latest … |